Product Details
Synonyms
FCGR
Source
Rat CD32b Protein, His Tag (CDB-R52H3) is expressed from human 293 cells (HEK293). It contains AA His 32 - Pro 212 (Accession # Q63203).
Predicted N-terminus: His 32
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 22.4 kDa. The protein migrates as 33-45 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Rat CD32b Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
SEC-MALS

The purity of Rat CD32b Protein, His Tag (Cat. No. CDB-R52H3) is more than 90% and the molecular weight of this protein is around 30-40 kDa verified by SEC-MALS.
Report
Bioactivity-SPR

GMP Monoclonal Anti-Human CD3 Antibody (OKT3) (Cat. No. GMP-MC0323) immobilized on CM5 Chip can bind Rat CD32b Protein, His Tag (Cat. No. CDB-R52H3) with an affinity constant of 1.93 μM as determined in a SPR assay (Biacore 8K) (QC tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Low affinity immunoglobulin gamma Fc region receptor II-b
- Category:
- Approved Drugs:
0 Details
- Drugs in Clinical Trials:
5 Details
- Highest Development Stage:
Phase 3 Clinical
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521



















